Literature DB >> 20724520

Peritonitis and exit site infections in First Nations patients on peritoneal dialysis.

Ainslie Hildebrand1, Paul Komenda, Lisa Miller, Claudio Rigatto, Mauro Verrelli, Amy R Sood, Chris Sathianathan, Martina Reslerova, Loretta Eng, Amanda Eng, Manish M Sood.   

Abstract

BACKGROUND AND OBJECTIVES: First Nations (FN) patients on peritoneal dialysis experience poor outcomes. Whether discrepancies exist regarding the microbiology, rate of infections, and outcomes between FN and non-FN peoples remains unknown. Design, setting, participants, & measures: All adult peritoneal dialysis patients (n = 727) from 1997 to 2007 residing in Manitoba, Canada, were included. Parametric and nonparametric tests were used as necessary. Negative binomial regression was used to determine the relationship of rates of exit site infections (ESIs) and peritonitis between FN and non-FN peoples.
RESULTS: A total of 161 FN and 566 non-FN subjects were included in the analyses. The unadjusted relative rates of peritonitis and ESIs in FN subjects were 132.7 and 86.0/100 patient-years compared with 87.8 and 78.2/100 patient-years in non-FN populations, respectively. FN subjects were more likely to have culture-negative peritonitis (36.5 versus 20.8%, P < 0.0001) and Staphylococcus ESIs (54.1 versus 32.9%, P < 0.0001). The crude and adjusted rates of peritonitis were higher in FN subjects for total episodes and culture-negative and gram-negative peritonitis. Catheter removal because of peritonitis was similar in both groups (42.9 versus 38.1% for FN and non-FN subjects, respectively; P = 0.261).
CONCLUSIONS: FN patients experience higher rates of peritonitis and similar rates of ESIs compared with non-FN patients. Interventions to improve outcomes and prevent infections should specifically be targeted to the FN population.

Entities:  

Mesh:

Year:  2010        PMID: 20724520      PMCID: PMC3001768          DOI: 10.2215/CJN.04170510

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  21 in total

1.  Adverse outcomes among Aboriginal patients receiving peritoneal dialysis.

Authors:  Manish M Sood; Paul Komenda; Amy R Sood; Martina Reslerova; Mauro Verrelli; Chris Sathianathan; Loretta Eng; Amanda Eng; Claudio Rigatto
Journal:  CMAJ       Date:  2010-07-26       Impact factor: 8.262

2.  Disparities in chronic disease risk factors and health status between American Indian/Alaska Native and White elders: findings from a telephone survey, 2001 and 2002.

Authors:  Clark H Denny; Deborah Holtzman; R Turner Goins; Janet B Croft
Journal:  Am J Public Health       Date:  2005-05       Impact factor: 9.308

3.  Complications of Type 2 Diabetes Among Aboriginal Canadians: prevalence and associated risk factors.

Authors:  Anthony J G Hanley; Stewart B Harris; Mary Mamakeesick; Ken Goodwin; Edith Fiddler; Robert A Hegele; J David Spence; Andrew A House; Ed Brown; Blair Schoales; John R McLaughlin; Ronald Klein; Bernard Zinman
Journal:  Diabetes Care       Date:  2005-08       Impact factor: 19.112

Review 4.  Peritoneal dialysis-related infections recommendations: 2005 update.

Authors:  Beth Piraino; George R Bailie; Judith Bernardini; Elisabeth Boeschoten; Amit Gupta; Clifford Holmes; Ed J Kuijper; Philip Kam-Tao Li; Wai-Choong Lye; Salim Mujais; David L Paterson; Miguel Perez Fontan; Alfonso Ramos; Franz Schaefer; Linda Uttley
Journal:  Perit Dial Int       Date:  2005 Mar-Apr       Impact factor: 1.756

5.  Use and outcomes of peritoneal dialysis among Aboriginal people in Canada.

Authors:  Marcello Tonelli; Brenda Hemmelgarn; Braden Manns; Sara Davison; Clara Bohm; Sita Gourishankar; George Pylypchuk; Karen Yeates; John S Gill
Journal:  J Am Soc Nephrol       Date:  2004-12-08       Impact factor: 10.121

6.  Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA.

Authors:  Wai H Lim; David W Johnson; Stephen P McDonald
Journal:  Nephrology (Carlton)       Date:  2005-04       Impact factor: 2.506

Review 7.  Aboriginal health.

Authors:  H L MacMillan; A B MacMillan; D R Offord; J L Dingle
Journal:  CMAJ       Date:  1996-12-01       Impact factor: 8.262

8.  Current incidence, treatment patterns and outcome of end-stage renal disease among indigenous groups in Australia and New Zealand.

Authors:  Stephen P McDonald; Graemer R Russ
Journal:  Nephrology (Carlton)       Date:  2003-02       Impact factor: 2.506

9.  A diabetes mellitus in the First Nations population of British Columbia, Canada. Part 1. Mortality.

Authors:  Andrew Jin; J David Martin; Christopher Sarin
Journal:  Int J Circumpolar Health       Date:  2002-08       Impact factor: 1.228

10.  Death and renal transplantation among Aboriginal people undergoing dialysis.

Authors:  Marcello Tonelli; Brenda Hemmelgarn; Braden Manns; George Pylypchuk; Clara Bohm; Karen Yeates; Sita Gourishankar; John S Gill
Journal:  CMAJ       Date:  2004-09-14       Impact factor: 8.262

View more
  11 in total

1.  Procalcitonin: diagnostic value in systemic infections in chronic kidney disease or renal transplant patients.

Authors:  Raluca Dumea; Dimitrie Siriopol; Simona Hogas; Irina Mititiuc; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2013-08-30       Impact factor: 2.370

Review 2.  Can procalcitonin be used to distinguish between disease flare and infection in patients with systemic lupus erythematosus: a systematic literature review.

Authors:  Ilaria Serio; Laurent Arnaud; Alexis Mathian; Pierre Hausfater; Zahir Amoura
Journal:  Clin Rheumatol       Date:  2014-07-27       Impact factor: 2.980

3.  Predictive value of procalcitonin for diagnosis of infections in patients with chronic kidney disease: a comparison with traditional inflammatory markers C-reactive protein, white blood cell count, and neutrophil percentage.

Authors:  Yanbei Sun; Lijuan Jiang; Xiaonan Shao
Journal:  Int Urol Nephrol       Date:  2017-09-27       Impact factor: 2.370

4.  Racial Differences in Home Dialysis Utilization and Outcomes in Canada.

Authors:  Emilie Trinh; Yingbo Na; Manish M Sood; Christopher T Chan; Jeffrey Perl
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-23       Impact factor: 8.237

5.  Association of modality with mortality among Canadian Aboriginals.

Authors:  Manish M Sood; Brenda Hemmelgarn; Claudio Rigatto; Paul Komenda; Karen Yeates; Steven Promislow; Julie Mojica; Navdeep Tangri
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-20       Impact factor: 8.237

Review 6.  Periprocedural Peritonitis Prophylaxis: A Summary of the Microbiology and the Role of Systemic Antimicrobials.

Authors:  Leon Hsueh; Susie L Hu; Ankur D Shah
Journal:  Kidney Dis (Basel)       Date:  2021-02-18

Review 7.  Continuous ambulatory peritoneal dialysis: perspectives on patient selection in low- to middle-income countries.

Authors:  Nicola Wearne; Kajiru Kilonzo; Emmanuel Effa; Bianca Davidson; Peter Nourse; Udeme Ekrikpo; Ikechi G Okpechi
Journal:  Int J Nephrol Renovasc Dis       Date:  2017-01-04

8.  Is Assisted Peritoneal Dialysis a Solution for Northern Manitoba?

Authors:  Josée G Lavoie; James Zacharias; Joseph Kaufert; Nicholas Krueger; Kathi Avery Kinew; Lorraine Mcleod; Caroline Chartrand
Journal:  Healthc Policy       Date:  2019-05

9.  Risk factors associated with peritoneal-dialysis-related peritonitis.

Authors:  Julia Kerschbaum; Paul König; Michael Rudnicki
Journal:  Int J Nephrol       Date:  2012-12-20

10.  A Retrospective Study of Chronic Kidney Disease Burden in Saskatchewan's First Nations People.

Authors:  Dorothy A Thomas; Anne Huang; Michelle C E McCarron; Joanne E Kappel; Rachel M Holden; Karen E Yeates; Bonnie R Richardson
Journal:  Can J Kidney Health Dis       Date:  2018-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.